Corrinne Burns

Royal Pharmaceutical Society Correspondent

Corrinne Burns is Royal Pharmaceutical Society Correspondent at The Pharmaceutical Journal.

NICE approves brain cancer drug following change to cost-effectiveness thresholds

Vorasidenib, a daily pill, has been approved for people aged over 12 years who have astrocytoma or oligodendroglioma with isocitrate dehydrogenase IDH1 or IDH2 mutations.…

RPS Charter Award given for pharmacist’s ‘global impact’

The Royal Pharmaceutical Society said Catherine Duggan has been “a strong advocate for improving access to safe, effective and high-quality pharmaceutical care”.…

Director of pharmacy appointed for Royal College of Pharmacy

Justine Scanlan will lead on the royal college's ambitions to champion pharmacy with policymakers, partners and stakeholders across Great Britain.…

Weight-loss drug to be offered to patients at risk of stroke or heart attack

In response to the new recommendation, sector leaders have called for the NHS to “mobilise the pharmacy network” as weight-loss medications are offered to an increasing number of patients.…

First neighbourhood health centres to open by 2027

The government said that up to £50m has been pledged to support the rollout of the first 27 neighbourhood health centres across England.…

Non-pharmacological interventions should be first step in managing chronic pain, guidance says

The Scottish government has recommended that clinicians should offer non-pharmacological resources as part of personalised pain management plans, which may also include pharmacological management.…

Medicines shortages report recognises progress but says ‘decisive steps’ are still needed

One year on from its medicines shortages report, the RPS has highlighted that the burden on community pharmacies, general practice and hospitals to manage medicines shortages is still “unsustainably high”.…

Pharmacies administered more than 10% of all vaccines in RSV pilot

The NHS pilot was aimed to test the potential for community pharmacies to increase equity in access to the respiratory syncytial virus vaccine.…

Additional Responsible Pharmacist requirements would make pharmacy practice ‘more difficult’, says RPS

In response to a General Pharmaceutical Council consultation, the Royal Pharmaceutical Society said that additional criteria for Responsible Pharmacists could undermine the delivery of services.…

Coroner calls for greater recognition of clinical significance of ‘excessive’ salbutamol inhaler use

A patient died in December 2023 after using an salbutamol inhaler more than frequently than recommended.…